HLA-G +3142 polymorphism as a susceptibility marker in two rheumatoid arthritis populations in Brazil

Tissue Antigens

Volumn 83, Issue 4, 2014, Pages 260-266

  Veit, T D ^a   De Lima, C P S ^b   Cavalheiro, L C ^c   Callegari Jacques, S M ^a   Brenol, C V ^c   Brenol, J C T ^c   Xavier, R M ^c   Da Cunha Sauma, M F L ^b   Dos Santos, E J M ^b   Chies, J A B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

14bp; 3' untranslated region; Brazil; Disease susceptibility; Haplotype; Human leukocyte antigen G; Polymorphism; Rheumatoid arthritis

Indexed keywords

DNA; HLA G ANTIGEN;

ADULT; ALLELE; ARTICLE; BRAZIL; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

14 BP; 3′-UNTRANSLATED REGION; BRAZIL; DISEASE SUSCEPTIBILITY; HAPLOTYPE; HUMAN LEUKOCYTE ANTIGEN-G; POLYMORPHISM; RHEUMATOID ARTHRITIS;

3' UNTRANSLATED REGIONS; ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; BRAZIL; FEMALE; GENE FREQUENCY; HLA-G ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 84896315149     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12311     Document Type: Article

References (25)

1. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995: 22: 1032-6.
2. Perricone C, Ceccarelli F, Valesini G. An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev 2011: 10: 599-608.
3. Riteau B, Menier C, Khalil-Daher I et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 2001: 13: 193-201.
4. Riteau B, Menier C, Khalil-Daher I et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999: 43: 203-11.
5. Bahri R, Hirsch F, Josse A et al. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 2006: 176: 1331-9.
6. LeMaoult J, Caumartin J, Daouya M et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007: 109: 2040-8.
7. Caumartin J, Favier B, Daouya M et al. Trogocytosis-based generation of suppressive NK cells. EMBO J 2007: 26: 1423-33.
8. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001: 13: 385-94.
9. Carosella ED, HoWangYin K-Y, Favier B, LeMaoult J. HLA-G-dependent suppressor cells: diverse by nature, function, and significance. Hum Immunol 2008: 69: 700-7.
10. Castelli EC, Moreau P, Oya e Chiromatzo A et al. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol 2009: 70: 1020-5.
11. Veit TD, Vianna P, Scheibel I et al. Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis. Tissue Antigens 2008: 71: 440-6.
12. Rizzo R, Rubini M, Govoni M et al. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 2006: 16: 615-23.
13. Consiglio CR, Veit TD, Monticielo OA et al. Association of the HLA-G gene +3142C>G polymorphism with systemic lupus erythematosus. Tissue Antigens 2011: 77: 540-5.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-24.
15. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991: 19: 5444.
16. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002: 60: 122-32.
17. Cordero EA, Veit TD, da Silva MA, Jacques SM, Silla LM, Chies JA. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 2009: 74: 308-13.
18. Long JC. Multiple Locus Haplotype Analysis, 3.0 edn. Software and documentation distributed by the author. Bethesda, MD, Section on Population Genetics and Linkage, Laboratory of Neurogenetics, NIAAA, National Institutes of Health, 1999.
19. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995: 56: 799-810.
20. Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004: 1: 6.
21. Rizzo R, Farina I, Bortolotti D et al. HLA-G may predict the disease course in patients with early rheumatoid arthritis. Hum Immunol 2013: 74: 425-32.
22. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol 2011: 28: 3069-86.
23. Santos KE, Lima TH, Felício LP et al. Insights on the HLA-G Evolutionary history provided by a nearby Alu insertion. Mol Biol Evol 2013: 30: 2423-34.
24. Martelli-Palomino G, Pancotto JA, Muniz YC et al. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential HLA-G soluble levels in the Brazilian and French population. PLoS One 2013: 8: e71742.
25. Anaya J-M, Gómez L, Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clin Dev Immunol 2006: 13: 185-9.